首页> 外文期刊>Oncology reports >Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles
【24h】

Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles

机译:改善了包裹在MPEG-PCL纳米颗粒中的阿霉素的抗肿瘤活性并降低了心肌毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Doxorubicin (Dox) is a broad-spectrum antitumor drug used for the treatment of many types of malignant tumors. Although it possesses powerful antitumor activity, its clinical application is seriously encumbered by its unselective distribution and systemic toxicities, particularly myocardial toxicity. Thus, it is imperative to modify Dox to decrease its systemic toxicities and improve its therapeutic index. In the present study, we adopted a novel type of monomethoxy poly(ethylene glycol)-poly(epsilon-caprolactone) (MPEG-PCL) micelles to encapsulate Dox to prepare Dox-loaded MPEG-PCL (Dox/MPEG-PCL) nanoparticles by a controllable self-assembly process. The cellular uptake efficiency and cell proliferation inhibition of the Dox/MPEG-PCL nanoparticles were examined. The antitumor activity of the Dox/MPEG-PCL nanoparticles was tested on a multiple pulmonary metastasis model of melanoma on C57BL/6 mice. Systemic toxicities and survival time were compared between the mice treated with the Dox/MPEG-PCL nanoparticles and free Dox. The potential myocardial toxicity of the Dox/MPEG-PCL nanoparticles was investigated using a prolonged observation period. Encapsulation of Dox in MPEG-PCL nanoparticles significantly improved the cellular uptake and cell proliferation inhibition of Dox in vivo. Intravenous injection of Dox/MPEG-PCL nanoparticles obtained significant inhibition of the growth and metastasis of melanoma in the lung and prolonged survival time compared with free Dox (P<0.05). The Dox/MPEG-PCL nanoparticles did not show obvious additional systemic toxicities compared with free Dox during the treatment time. During the prolonged observation period, obvious decreased cardiac toxicity was observed in the Dox/MPEG-PCL nanoparticle-treated mice compared with that observed in the free Dox-treated mice. These results indicated that encapsulating Dox with MPEG-PCL micelles could significantly promote its antitumor activity and reduce its toxicity to the myocardium.
机译:阿霉素(Dox)是一种广谱抗肿瘤药物,用于治疗多种类型的恶性肿瘤。尽管它具有强大的抗肿瘤活性,但其非选择性的分布和全身毒性(尤其是心肌毒性)严重阻碍了其临床应用。因此,必须对Dox进行修饰以降低其全身毒性并改善其治疗指数。在本研究中,我们采用一种新型的单甲氧基聚(乙二醇)-聚(ε-己内酯)(MPEG-PCL)胶束来封装Dox,从而通过以下方法制备载有Dox的MPEG-PCL(Dox / MPEG-PCL)纳米颗粒可控的自组装过程。检查了Dox / MPEG-PCL纳米粒子的细胞摄取效率和细胞增殖抑制作用。在C57BL / 6小鼠的黑色素瘤的多发性肺转移模型上测试了Dox / MPEG-PCL纳米颗粒的抗肿瘤活性。比较了用Dox / MPEG-PCL纳米颗粒和游离Dox处理的小鼠的全身毒性和存活时间。使用延长的观察期研究了Dox / MPEG-PCL纳米颗粒的潜在心肌毒性。 Dox在MPEG-PCL纳米粒子中的封装显着改善了Dox在体内的细胞摄取和细胞增殖抑制。与游离Dox相比,静脉注射Dox / MPEG-PCL纳米粒子可显着抑制黑色素瘤在肺中的生长和转移,并延长了生存时间(P <0.05)。与游离Dox相比,Dox / MPEG-PCL纳米粒子在治疗期间没有显示出明显的其他全身毒性。在延长的观察期中,与在自由的Dox处理的小鼠中观察到的相比,在Dox / MPEG-PCL纳米颗粒处理的小鼠中观察到了明显的心脏毒性降低。这些结果表明,用MPEG-PCL胶束包裹Dox可以显着增强其抗肿瘤活性并降低其对心肌的毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号